EXAS
NASDAQ
US
Exact Sciences Corporation - Common Stock
$104.91
▲ +$0.00
(+0.00%)
6
Quality Score
fail
Rev ✗
NI ✗
>IPO ✗
Mkt Cap
$19.3B
ROE
-40.4%
Margin
-32.0%
D/E
93.52
Beta
1.41
52W
$39–$103
Wall Street Consensus
29 analysts · Apr 20262
Strong Buy
6
Buy
21
Hold
0
Sell
0
Strong Sell
27.6%
Buy Rating
Price Chart
Similar Stocks
ALNY
Alnylam Pharmaceuticals Inc
P/E 1205.9
$52.5B
INSM
Insmed Inc
$37.1B
NTRA
Natera Inc
$31.7B
BIIB
Biogen Inc
P/E 16.0
$25.8B
UTHR
United Therapeutics Corp
P/E 16.5
$21.0B
RVMD
Revolution Medicines Inc
$15.4B
MRNA
Moderna Inc
$11.5B
INCY
Incyte Corp
P/E 16.3
$19.4B
SMMT
Summit Therapeutics Inc
$13.0B
BBIO
BridgeBio Pharma Inc
$14.7B
Earnings
Beat rate: 25.0%| Quarter | EPS Est | EPS Act | Surprise |
|---|---|---|---|
| Dec 2025 | $-0.07 | $-0.38 | $-0.31 |
| Sep 2025 | $-0.07 | $-0.10 | $-0.03 |
| Jun 2025 | $-0.18 | $-0.01 | +$0.17 |
| Mar 2025 | $-0.39 | $-0.54 | $-0.15 |
Fundamentals Trend
| Metric | 2025-06-30 | 2025-09-02 | 2025-10-02 | 2025-11-03 | 2025-12-03 | 2026-01-02 |
|---|---|---|---|---|---|---|
| ROE (TTM) | -38.4% | -38.4% | -38.4% | -38.4% | -40.4% | -40.4% |
| P/E (TTM) | — | — | — | — | — | — |
| Net Margin | -0.1% | -34.2% | -34.2% | -34.2% | -32.0% | -32.0% |
| Gross Margin | 69.3% | 68.2% | 68.2% | 68.2% | 67.4% | 67.4% |
| D/E Ratio | 94.74 | 94.74 | 94.74 | 94.74 | 93.52 | 93.52 |
| Current Ratio | 2.89 | 2.89 | 2.89 | 2.89 | 2.72 | 2.72 |
Key Ratios
ROA (TTM)
-16.9%
P/S (TTM)
6.26
P/B
4.3
EPS (TTM)
$-5.32
CF/Share
$-0.44
Rev Growth 3Y
+16.0%
52W High
$102.66
52W Low
$38.81
$38.81
52-Week Range
$102.66
How does EXAS compare to Biotechnology peers?
Peer group: Micro-cap Biotechnology (All) · 528 companies
EXAS valuation vs Biotechnology peers
P/E ratio
—
▼
0%
below
peers
(18.8)
vs Peers
vs Industry
Undervalued
P/S ratio
6.3
▼
51%
below
peers
(12.9)
vs Peers
vs Industry
Undervalued
P/B ratio
4.3
▲
76%
above
peers
(2.5)
vs Peers
vs Industry
Overvalued
Div yield
—
▼
0%
below
peers
(0.0%)
vs Peers
vs Industry
Low yield
EXAS profitability vs Biotechnology peers
ROE
-40.4%
▲
40%
above
peers
(-67.3%)
vs Peers
vs Industry
Below avg
Net margin
-32.0%
▲
89%
above
peers
(-286.8%)
vs Peers
vs Industry
Below avg
Gross margin
67.4%
▼
14%
below
peers
(78.6%)
vs Peers
vs Industry
Weak
ROA
-16.9%
▲
64%
above
peers
(-46.7%)
vs Peers
vs Industry
Top tier
EXAS financial health vs Biotechnology peers
D/E ratio
93.5
▼
0%
below
peers
(0.0)
vs Peers
vs Industry
High debt
Current ratio
2.7
▼
39%
below
peers
(4.4)
vs Peers
vs Industry
Low liquidity
Beta
1.4
▲
46%
above
peers
(1.0)
vs Peers
vs Industry
More volatile
EXAS fundamentals radar
EXAS
Peer median
Industry
EXAS profitability vs leverage
Bubble size = market cap · X = net margin · Y = D/E ratio
EXAS vs peers: key metrics
Latest News
A Texas man convinced investors to bet $1 million on his business. …
Yahoo Finance · Apr 05
Forget Temu's "Bugatti" Knockoff. Texas Man 3D-Printed A Lamborghini Aventador Body
ZeroHedge · Apr 05
I'm Making a Bold Call on Texas Instruments Stock. Here's My Reasoning.
Yahoo Finance · Apr 03
Sharia Law In Texas? Rep Exposes Muslim-Only Enclaves Operating Next To Police …
ZeroHedge · Apr 02
Alarming West Texas Oil Theft Emerges As National Security Threat
ZeroHedge · Mar 28